Article may be outdated

This article is 52 days old. Some details may have changed since publication.

Newswise·4 min read·hard

A fourth T6SS in clinical Pseudomonas aeruginosa deploys the pore-forming effector TseMt

A fourth T6SS in clinical Pseudomonas aeruginosa deploys the pore-forming effector TseMt
✦AI Summary

Scientists have identified a fourth type VI secretion system (H4-T6SS) in clinical strains of Pseudomonas aeruginosa. The study reveals that this system, when activated, deploys a pore-forming toxin called TseMt to kill competing bacteria.

Why it matters

This discovery provides insight into the virulence mechanisms of hospital-acquired pathogens, potentially aiding in the development of new antimicrobial strategies.

✦Dive DeeperCreate a free account to unlock

Model of H4-T6SS-mediated TseMt delivery and function in clinical Pseudomonas aeruginosa LYSZa7

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealth
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in